1998 Journal Article The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UKRees, E, Hardy, J, Ling, J, Broadley, K and A'Hern, R (1998). The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliative Medicine, 12 (2), 75-82. doi: 10.1191/026921698674135173 |
1997 Journal Article Placebo-controlled trials in palliative care: the argument forHardy, JR (1997). Placebo-controlled trials in palliative care: the argument for. Palliative Medicine, 11 (5), 415-418. doi: 10.1177/026921639701100514 |
1997 Journal Article Palliative medicine in cancerStone, Patrick and Hardy, Janet (1997). Palliative medicine in cancer. The Lancet, 350 (9073), 296. doi: 10.1016/s0140-6736(05)62270-2 |
1997 Journal Article Can transdermal fentanyl cause diarrhea?Hardy, Janet R. (1997). Can transdermal fentanyl cause diarrhea?. Journal of Pain and Symptom Management, 13 (4), 188-189. doi: 10.1016/s0885-3924(97)00037-7 |
1995 Journal Article Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD)Ling, P. J., Ahern, R. P. and Hardy, J. R. (1995). Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). British Journal of Cancer, 72 (1), 206-209. doi: 10.1038/bjc.1995.304 |
1995 Journal Article Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancerEllis, P. A., Smith, I. E., Hardy, J. R., Nicolson, M. C., Talbot, D. C., Ashley, S. E. and Priest, K. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. British Journal of Cancer, 71 (2), 366-370. doi: 10.1038/bjc.1995.74 |
1995 Journal Article Subcutaneous KetorolacDuncan, AR, Hardy, JR and Davis, CL (1995). Subcutaneous Ketorolac. Palliative Medicine, 9 (1), 77-78. doi: 10.1177/026921639500900111 |
1994 Journal Article Current issues in cancer palliative careDavis, C. L. and Hardy, J. R. (1994). Current issues in cancer palliative care. BMJ, 308 (6940), 1359-1362. doi: 10.1136/bmj.308.6940.1359 |
1994 Journal Article Prediction of Survival in a Hospital-Based Continuing Care UnitHardy, JR, Turner, R, Saunders, M and Ahern, R (1994). Prediction of Survival in a Hospital-Based Continuing Care Unit. European Journal of Cancer, 30A (3), 284-288. doi: 10.1016/0959-8049(94)90242-9 |
1994 Journal Article An audit of morphine prescribing in a specialist cancer hospitalTurner, Rose, Clark, Judith, Root, Timothy and Hardy, Janet (1994). An audit of morphine prescribing in a specialist cancer hospital. Palliative Medicine, 8 (1), 5-10. doi: 10.1177/026921639400800102 |
1992 Journal Article A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-CancerObrien, Mer, Hardy, J, Tan, S, Walling, J, Peters, B, Hatty, S and Wiltshaw, E (1992). A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer. Cancer Chemotherapy and Pharmacology, 30 (3), 245-248. doi: 10.1007/BF00686324 |
1991 Journal Article Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-CancerHarvey, VJ, Hardy, JR, Smith, S, Grove, W and Baguley, BC (1991). Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer. European Journal of Cancer, 27 (12), 1617-1620. doi: 10.1016/0277-5379(91)90427-F |
1991 Journal Article Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 CasesFossella, FV, Lippman, SM, Seitz, DE, Alberts, DS, Taylor, CW, Wiltshaw, E, Hardy, J, Obrien, M, Haynes, TR and Wolen, RL (1991). Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases. Investigational New Drugs, 9 (4), 357-359. |
1991 Journal Article Lymphedema - Prevention Rather Than CureHardy, JR (1991). Lymphedema - Prevention Rather Than Cure. Annals of Oncology, 2 (8), 532-533. doi: 10.1093/oxfordjournals.annonc.a058015 |
1991 Journal Article A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerPowles, T. J., Jones, A. L., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1991). A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. British Journal of Cancer, 64 (2), 406-410. doi: 10.1038/bjc.1991.318 |
1991 Journal Article The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer PatientsNewell, DR, Mansi, J, Hardy, J, Button, D, Jenns, K, Smith, IE, Picollo, R and Catanese, B (1991). The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients. Seminars in Oncology, 18 (2), 11-17. |
1991 Journal Article Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-CarcinomaHardy, JR, Wiltshaw, E, Blake, PR, Harper, P, Slevin, M, Perren, TJ and Tan, S (1991). Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma. Annals of Oncology, 2 (2), 131-136. doi: 10.1093/oxfordjournals.annonc.a057876 |
1991 Journal Article Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-CancerJones, AL, Hardy, JR, Newell, DR and Smith, IE (1991). Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer. European Journal of Cancer, 27 (4), 519-519. doi: 10.1016/0277-5379(91)90403-Z |
1990 Conference Publication NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCERHARDY, J, TAN, S, FRYATT, and WILTSHAW, E (1990). NEED NEPHROTOXICITY LIMIT DOSE INTENSITY STRATEGIES IN OVARIAN-CANCER. BASINGSTOKE: STOCKTON PRESS. |
1990 Journal Article Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancerJones, A. L., Williams, M. P., Powles, T. J., Oliff, J. F. C., Hardy, J. R., Cherryman, G. and Husband, J. (1990). Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer. British Journal of Cancer, 62 (2), 296-298. doi: 10.1038/bjc.1990.281 |